| Literature DB >> 32245209 |
Claudio Giovanni De Angelis1, Pablo Cortegoso Valdivia1, Stefano Rizza1, Ludovica Venezia1, Felice Rizzi1, Marcantonio Gesualdo1, Giorgio Maria Saracco1, Rinaldo Pellicano1.
Abstract
Endoscopic injection of glues, clotting factors, or sclerosing agents is a well-known therapy for the treatment of non-variceal upper gastrointestinal bleeding (NVUGIB), but less is known about endoscopic ultrasound (EUS)-guided treatments. In this setting, literature data are scarce, and no randomized controlled trials are available. We performed a review of the existing literature in order to evaluate the role of EUS-guided therapies in the management of NVUGIB. The most common treated lesions were Dieulafoy's lesions, pancreatic pseudoaneurysms, and gastrointestinal stromal tumors (GISTs). Mostly, the treatments were performed as a salvage option after failure of conventional endoscopic hemostatic attempts, showing good efficacy and a good safety profile, also documented by Doppler monitoring of treated lesions. EUS-guided therapies may be an effective option in the treatment of refractory NVUGIB, thus avoiding radiological or surgical management. Nevertheless, available literature still lacks robust data.Entities:
Keywords: Dieulafoy; EUS; bleeding; endotherapy; hemostasis; pseudoaneurysm
Year: 2020 PMID: 32245209 DOI: 10.3390/jcm9030866
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241